109 related articles for article (PubMed ID: 22391230)
1. Immunogenicity of recombinant human erythropoietin in Korea: a two-year cross-sectional study.
Shin SK; Moon SJ; Ha SK; Jo YI; Lee TW; Lee YS; Kim YW; Kim DJ; Kim JK; Yoo TH; Lee KB; Choi SO; Kang EW; Lee KW; Kim SJ; Kim SK; Heo TH
Biologicals; 2012 Jul; 40(4):254-61. PubMed ID: 22391230
[TBL] [Abstract][Full Text] [Related]
2. Assays for detecting and diagnosing antibody-mediated pure red cell aplasia (PRCA): an assessment of available procedures.
Thorpe R; Swanson SJ
Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv16-22. PubMed ID: 15827053
[TBL] [Abstract][Full Text] [Related]
3. Development and characterization of a human antibody reference panel against erythropoietin suitable for the standardization of ESA immunogenicity testing.
Mytych DT; Barger TE; King C; Grauer S; Haldankar R; Hsu E; Wu MM; Shiwalkar M; Sanchez S; Kuck A; Civoli F; Sun J; Swanson SJ
J Immunol Methods; 2012 Aug; 382(1-2):129-41. PubMed ID: 22634015
[TBL] [Abstract][Full Text] [Related]
4. Application of a bridging ELISA for detection of anti-erythropoietin binding antibodies and a cell-based bioassay for neutralizing antibodies in human sera.
Shin SK; Ha SK; Lee KW; Yoo TH; Yun SR; Yoon SH; Kim SJ; Lee SK; Heo TH
J Pharm Biomed Anal; 2010 Jun; 52(2):289-93. PubMed ID: 20133098
[TBL] [Abstract][Full Text] [Related]
5. Anti-erythropoietin and anti-thrombopoietin antibodies induced after administration of recombinant human erythropoietin.
Shin SK; Pack SP; Oh JG; Kang NK; Chang MH; Chung YH; Kim SJ; Lee JW; Heo TH
Int Immunopharmacol; 2011 Dec; 11(12):2237-41. PubMed ID: 22051973
[TBL] [Abstract][Full Text] [Related]
6. [Pure red cell aplasia in patients treated with recombinant erythropoietin for anemia due to chronic renal disease].
Miyazaki T; Obana T; Takasaki H; Tanaka M; Yamaji S; Fujimaki K; Fujita H; Kanamori H; Ishigatsubo Y
Rinsho Ketsueki; 2007 May; 48(5):391-6. PubMed ID: 17571584
[TBL] [Abstract][Full Text] [Related]
7. What is antibody-mediated pure red cell aplasia (PRCA)?
Casadevall N
Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv3-8. PubMed ID: 15827056
[TBL] [Abstract][Full Text] [Related]
8. High prevalence in Switzerland of pure red-cell aplasia due to anti-erythropoietin antibodies in chronic dialysis patients: report of five cases.
Schönholzer C; Keusch G; Nigg L; Robert D; Wauters JP
Nephrol Dial Transplant; 2004 Aug; 19(8):2121-5. PubMed ID: 15252171
[TBL] [Abstract][Full Text] [Related]
9. Incidence of recombinant erythropoietin (EPO) hyporesponse, EPO-associated antibodies, and pure red cell aplasia in dialysis patients.
Kharagjitsingh AV; Korevaar JC; Vandenbroucke JP; Boeschoten EW; Krediet RT; Daha MR; Dekker FW;
Kidney Int; 2005 Sep; 68(3):1215-22. PubMed ID: 16105053
[TBL] [Abstract][Full Text] [Related]
10. Prevalence of anti-erythropoietin antibodies in hemodialysis patients without clinical signs of pure red cell aplasia. Comparison between hypo- and normoresponsive patients treated with epoetins for renal anemia.
Stoffel MP; Haverkamp H; Kromminga A; Lauterbach KW; Baldamus CA
Nephron Clin Pract; 2007; 105(2):c90-8. PubMed ID: 17164586
[TBL] [Abstract][Full Text] [Related]
11. Hematide is immunologically distinct from erythropoietin and corrects anemia induced by antierythropoietin antibodies in a rat pure red cell aplasia model.
Woodburn KW; Fan Q; Winslow S; Chen MJ; Mortensen RB; Casadevall N; Stead RB; Schatz PJ
Exp Hematol; 2007 Aug; 35(8):1201-8. PubMed ID: 17662888
[TBL] [Abstract][Full Text] [Related]
12. Pure red cell aplasia induced only by intravenous administration of recombinant human erythropoietin.
Shimizu H; Saitoh T; Ota F; Jimbo T; Tsukada Y; Murakami H; Nojima Y
Acta Haematol; 2011; 126(2):114-8. PubMed ID: 21654161
[TBL] [Abstract][Full Text] [Related]
13. [Early onset of anti- erythropoietin antibody-mediated pure red cell aplasia after commencement of subcutaneous administration of epoetin-β].
Tanaka A; Tsukada J; Morimoto H; Katsuragi T; Nakanishi T; Watanabe S; Hirase N; Motomura S
Rinsho Ketsueki; 2012 Jan; 53(1):110-2. PubMed ID: 22374534
[TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of a new ELISA for the detection and quantification of antierythropoietin antibodies in human sera.
Hoesel W; Gross J; Moller R; Kanne B; Wessner A; Müller G; Müller A; Gromnica-Ihle E; Fromme M; Bischoff S; Haselbeck A
J Immunol Methods; 2004 Nov; 294(1-2):101-10. PubMed ID: 15604020
[TBL] [Abstract][Full Text] [Related]
15. Two cases of pure red-cell aplasia due to anti-erythropoietin antibodies.
Yang J; Joo KW; Kim YS; Ahn C; Han JS; Kim S; Lee JS
J Nephrol; 2005; 18(1):102-5. PubMed ID: 15772931
[TBL] [Abstract][Full Text] [Related]
16. Pure red cell aplasia induced by anti-erythropoietin antibodies, well-controlled with tacrolimus.
Hashimoto K; Harada M; Kamijo Y
Int J Hematol; 2016 Oct; 104(4):502-5. PubMed ID: 27338269
[TBL] [Abstract][Full Text] [Related]
17. Anti-erythropoietin antibody-mediated pure red cell aplasia after treatment with recombinant erythropoietin products: recommendations for minimization of risk.
Cournoyer D; Toffelmire EB; Wells GA; Barber DL; Barrett BJ; Delage R; Forrest DL; Gagnon RF; Harvey EA; Laneuville P; Patterson BJ; Poon MC; Posen GA; Messner HA;
J Am Soc Nephrol; 2004 Oct; 15(10):2728-34. PubMed ID: 15466278
[TBL] [Abstract][Full Text] [Related]
18. Immunogenicity of erythropoietin and other growth factors.
Indiveri F; Murdaca G
Rev Clin Exp Hematol; 2002; Suppl 1():7-11. PubMed ID: 12735210
[TBL] [Abstract][Full Text] [Related]
19. Antibody-mediated pure red cell aplasia (PRCA): epidemiology, immunogenicity and risks.
Macdougall IC
Nephrol Dial Transplant; 2005 May; 20 Suppl 4():iv9-15. PubMed ID: 15827058
[TBL] [Abstract][Full Text] [Related]
20. Recommendations on haematological criteria for the diagnosis of epoetin-induced pure red cell aplasia.
Casadevall N; Cournoyer D; Marsh J; Messner H; Pallister C; Parker-Williams J; Rossert J
Eur J Haematol; 2004 Dec; 73(6):389-96. PubMed ID: 15522059
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
